|Inflammation and cancer: how hot is the link?|
BB Aggarwal, S Shishodia, SK Sandur, MK Pandey, G Sethi
Biochemical pharmacology 72 (11), 1605-1621, 2006
|The vascular endothelium and human diseases|
P Rajendran, T Rengarajan, J Thangavel, Y Nishigaki, D Sakthisekaran, ...
International journal of biological sciences 9 (10), 1057, 2013
|Curcumin: getting back to the roots|
S Shishodia, G Sethi, BB Aggarwal
Annals of the New York Academy of Sciences 1056 (1), 206-217, 2005
|Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS …|
SK Sandur, MK Pandey, B Sung, KS Ahn, A Murakami, G Sethi, ...
Carcinogenesis 28 (8), 1765-1773, 2007
|Nuclear factor-κB activation: from bench to bedside|
G Sethi, B Sung, BB Aggarwal
Experimental biology and medicine 233 (1), 21-31, 2008
|Targeting the STAT3 signaling pathway in cancer: role of synthetic and natural inhibitors|
KS Siveen, S Sikka, R Surana, X Dai, J Zhang, AP Kumar, BKH Tan, ...
Biochimica et Biophysica Acta (BBA)-reviews on cancer 1845 (2), 136-154, 2014
|Targeting signal‐transducer‐and‐activator‐of‐transcription‐3 for prevention and therapy of cancer: modern target but ancient solution|
BB Aggarwal, G Sethi, KS Ahn, SK Sandur, MK Pandey, ...
Annals of the New York Academy of Sciences 1091 (1), 151-169, 2006
|Thymoquinone: potential cure for inflammatory disorders and cancer|
CC Woo, AP Kumar, G Sethi, KHB Tan
Biochemical pharmacology 83 (4), 443-451, 2012
|Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-κB–regulated antiapoptotic and cell …|
A Bhardwaj, G Sethi, S Vadhan-Raj, C Bueso-Ramos, Y Takada, U Gaur, ...
Blood 109 (6), 2293-2302, 2007
|TNF: a master switch for inflammation to cancer|
G Sethi, B Sung, BB Aggarwal
Front Biosci 13 (2), 5094-5107, 2008
|Targeting transcription factor NF-κB to overcome chemoresistance and radioresistance in cancer therapy|
F Li, G Sethi
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1805 (2), 167-180, 2010
|Natural products as a gold mine for arthritis treatment|
D Khanna, G Sethi, KS Ahn, MK Pandey, AB Kunnumakkara, B Sung, ...
Current opinion in pharmacology 7 (3), 344-351, 2007
|Thymoquinone inhibits tumor angiogenesis and tumor growth through suppressing AKT and extracellular signal-regulated kinase signaling pathways|
T Yi, SG Cho, Z Yi, X Pang, M Rodriguez, Y Wang, G Sethi, BB Aggarwal, ...
Molecular cancer therapeutics 7 (7), 1789-1796, 2008
|The multifaceted role of curcumin in cancer prevention and treatment|
MK Shanmugam, G Rane, MM Kanchi, F Arfuso, A Chinnathambi, ...
Molecules 20 (2), 2728-2769, 2015
|Plumbagin (5-hydroxy-2-methyl-1, 4-naphthoquinone) suppresses NF-κB activation and NF-κB-regulated gene products through modulation of p65 and IκBα kinase activation, leading …|
SK Sandur, H Ichikawa, G Sethi, KS Ahn, BB Aggarwal
Journal of Biological Chemistry 281 (25), 17023-17033, 2006
|Celastrol, a novel triterpene, potentiates TNF-induced apoptosis and suppresses invasion of tumor cells by inhibiting NF-κB–regulated gene products and TAK1-mediated NF-κB …|
G Sethi, KS Ahn, MK Pandey, BB Aggarwal
Blood 109 (7), 2727-2735, 2007
|Multifaceted link between cancer and inflammation|
G Sethi, MK Shanmugam, L Ramachandran, AP Kumar, V Tergaonkar
Bioscience reports 32 (1), 1-15, 2012
|Role of pro-oxidants and antioxidants in the anti-inflammatory and apoptotic effects of curcumin (diferuloylmethane)|
SK Sandur, H Ichikawa, MK Pandey, AB Kunnumakkara, B Sung, G Sethi, ...
Free radical biology and medicine 43 (4), 568-580, 2007
|Targeting nuclear factor-κB activation pathway by thymoquinone: role in suppression of antiapoptotic gene products and enhancement of apoptosis|
G Sethi, KS Ahn, BB Aggarwal
Molecular cancer research 6 (6), 1059-1070, 2008
|From traditional Ayurvedic medicine to modern medicine: identification of therapeutic targets for suppression of inflammation and cancer|
BB Aggarwal, H Ichikawa, P Garodia, P Weerasinghe, G Sethi, ID Bhatt, ...
Expert opinion on therapeutic targets 10 (1), 87-118, 2006